Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series

Unresectable cholangiocarcinoma is poorly responded to chemotherapy, especially for the case refractory to gemcitabine and cisplatin. Here, we tested whether high expression of thymidine phosphorylase (TP) can be a predictive biomarker for the indicator for gemcitabine and doxifluridine combination...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Kang, Myoung Hee, Lee, Won Sup, Go, Se-Il, Kim, Moon Jin, Lee, Un Seok, Choi, Hye Jung, Kim, Dong Chul, Lee, Jeong-Hee, Kim, Hoon-Gu, Bae, Kyung Soo, Cho, Jae Min
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2014
Konular:
5700
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4603134/
https://ncbi.nlm.nih.gov/pubmed/25526478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000305
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller